A Feasibility Trial of Power Up
6. Dezember 2016 aktualisiert von: University College, London
A Feasibility Trial of Power Up: A Smartphone App to Support Young People to Make Shared Decisions in Therapy
There is an increasing demand for digital tools to empower young people with mental health difficulties (NHS England, 2015). Digital information, advice and mood tracking tools are increasingly being used to support child mental health. Evidence suggests that young people want to be active participants in their care and involved in decisions about their treatment. However, there is a lack of digital shared decision making tools available to support young people in Child and Adolescent Mental Health Services (CAMHS). This study aims to develop Power Up, a smartphone app to empower young people in CAMHS to make their voice heard and to participate more in decisions around their care.
The project will involve two phases:
- Development Phase -Developing Power Up according to the views and ideas expressed by young people, their parents/ carers, and clinicians in Patient and Public Involvement (PPI) sessions. -Conducting interviews and focus groups with 10 young people in CAMHS, 10 parents/ carers and 10 clinicians to review the acceptability of the content and format of Power Up.
- Feasibility testing Phase -Conducting a feasibility trial with 120 young people with emotional difficulties, aged 11-19 years, from three London CAMHS. 60 young people will receive treatment as usual and 60 will use Power Up alongside treatment as usual. Participant's ratings of empowerment, activation, and symptoms will be measured soon after their referral to the service. The same measures plus shared decision making questionnaires will be administered three months later.
The findings will inform the planning of a prospective cluster controlled trial. More broadly this trial will contribute an understanding of the feasibility and acceptability of developing and implementing a shared decision making app into CAMHS.
Studienübersicht
Studientyp
Interventionell
Einschreibung (Voraussichtlich)
120
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
-
London, Vereinigtes Königreich, E1 5NF
- Rekrutierung
- East London NHS Foundation Trust
-
Kontakt:
- Percy Aggett
- Telefonnummer: 2400 020 7426 2375
- E-Mail: Percy.Aggett@elft.nhs.uk
-
London, Vereinigtes Königreich, IG11 7LZ
- Rekrutierung
- North East London NHS Foundation Trust
-
Kontakt:
- Vivienne Okoh
- Telefonnummer: 53261 0300 555 1035
- E-Mail: Vivienne.Okoh@nelft.nhs.uk
-
London, Vereinigtes Königreich, NW3 5BA
- Rekrutierung
- The Tavistock and Portman NHS Foundation Trust
-
Kontakt:
- Emilios Lemoniatis
- Telefonnummer: 020 8938 2429
- E-Mail: ELemoniatis@tavi-port.nhs.uk
-
Hauptermittler:
- Emilios Lemoniatis
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
11 Jahre bis 19 Jahre (Kind, Erwachsene)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- Recently been referred to CAMHS (pre - first appointment)
- Presenting with emotional difficulties
- Clinician will have confirmed that the young person does not have any vulnerability which would make taking part in the study inappropriate to their context
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Kein Eingriff: Control Phase (No Power Up)
60 young people will receive CAMHS treatment as usual.
Measures of empowerment, activation, and symptoms will be completed by participants soon after their referral to the service.
The same measures plus shared decision making questionnaires will be administered three months later.
|
|
|
Experimental: Intervention Phase (Power Up)
60 young people use Power Up alongside CAMHS treatment as usual.
Measures of empowerment, activation, and symptoms will be completed by participants soon after their referral to the service.
The same measures plus shared decision making questionnaires and a Power Up feedback form will be administered three months later.
|
Smartphone phone app
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Shared Decision Making Questionnaire - 9 (SDM Q-9)
Zeitfenster: 3 months
|
This will be completed by young people at time two (three months into therapy).
The SDM Q-9 is a nine item patient reported shared decision making questionnaire.
|
3 months
|
|
CollaboRATE
Zeitfenster: 3 months
|
This will be completed by young people at time two (three months into therapy).
CollaboRATE is a three item patient reported shared decision making measure.
|
3 months
|
|
Experience of Service Questionnaire (ESQ)
Zeitfenster: 3 months
|
Four items from this questionnaire will be completed by young people at time two (three months into therapy) as a proxy measure of shared decision making.
The ESQ is a self-completion questionnaire that assesses children and young people's views of services with respect to accessibility, humanity of care, organisation of care and environment.
|
3 months
|
|
Dyadic OPTION scale
Zeitfenster: 3 months
|
This will be completed by clinicians at time two (three months into therapy).
The Dyadic OPTION scale is a 12- item instrument to measure the extent to which patients have been involved in shared decision making from the viewpoint of the clinician.
|
3 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Patient Activation Measure - Mental Health (PAM - MH)
Zeitfenster: 3 months
|
The PAM - MH will be completed by young people at time one (beginning of therapy) and time two (three months into therapy).
The PAM - MH is a patient reported tool for measuring engagement in mental healthcare.
|
3 months
|
|
Strengths and Difficulties questionnaire (SDQ)
Zeitfenster: 3 months
|
The SDQ will be completed by young people at time one (beginning of therapy) and time two (three months into therapy).
The SDQ is a self-report behavioural screening questionnaire for children and adolescents measuring symptoms and functioning.
|
3 months
|
|
Youth Efficacy / Empowerment Scale - Mental Health (YES - MH)
Zeitfenster: 3 months
|
The YES -MH will be completed by young people at time one (beginning of therapy) and time two (three months into therapy).
The YES - MH assesses youth perceptions of efficacy with respect to managing their own mental health condition ('Self'), managing their own services and supports ('Service'), and using their experience and knowledge to help peers and improve service systems ('System').
|
3 months
|
|
Client Receipt of Services Inventory (CSRI) - Children's Version.
Zeitfenster: 3 months
|
The CSRI will be completed by parents at time one (beginning of therapy) and time two (three months into therapy).
The CSRI provides information on service utilisation, as reported by the main carer of the child in the family.
|
3 months
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Did Not Attends (DNAs)
Zeitfenster: 3 months
|
Number of young person DNAs will be reported by the clinician.
|
3 months
|
|
Number of sessions attended
Zeitfenster: 3 months
|
The number of sessions attended by the young person will be reported by the clinician.
|
3 months
|
|
Type of therapy / intervention received
Zeitfenster: 3 months
|
The type of therapy / intervention received by the young person will be reported by the clinician.
|
3 months
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Miranda Wolpert, Professor, UCL & Anaa Freud National Centre for Children and Families
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn
1. September 2016
Primärer Abschluss (Voraussichtlich)
1. August 2017
Studienabschluss (Voraussichtlich)
1. September 2017
Studienanmeldedaten
Zuerst eingereicht
12. Oktober 2016
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
6. Dezember 2016
Zuerst gepostet (Schätzen)
9. Dezember 2016
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
9. Dezember 2016
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
6. Dezember 2016
Zuletzt verifiziert
1. Oktober 2016
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 16/0087
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .